Coherus Biosciences Inc (CHRS) is higher by Wednesday morning, with the stock increasing 0.95% in pre-market trading to 2.13. CHRS's short-term technical score of 43 indicates that the stock has traded less bullishly over the last month than 57% of stocks on the market. In the Biotechnology industry, which ranks 128 out of 146 industries, CHRS ranks higher than 63% of stocks. Coherus Biosciences Inc has fallen 20.08% over the past month, closing at $3.20 on November 1. During this period of time, the stock fell as low as $1.59 and as high as $3.73. CHRS has an average analyst recommendation of Strong Buy. The company has an average price target of $10.43.
CHRS has an Overall Score of 46. Find out what this means to you and get the rest of the rankings on CHRS!